Myrtle Beach, SC3 Active Studies

Advanced Solid Tumors Clinical Trials in Myrtle Beach, SC

Find 3 actively recruiting advanced solid tumors clinical trials in Myrtle Beach, SC. Connect with local research sites and explore new treatment options.

3
Active Trials
3
Sponsors
598
Enrolling

Recruiting Advanced Solid Tumors Studies in Myrtle Beach

About Advanced Solid Tumors Clinical Trials in Myrtle Beach

Advanced solid tumors refer to cancers that have grown beyond the original site or spread to distant organs. Many clinical trials enroll patients with various types of advanced solid tumors to test novel therapies. These trials often investigate immunotherapy, targeted therapy, and combination approaches.

There are currently 3 advanced solid tumors clinical trials recruiting participants in Myrtle Beach, SC. These studies are seeking a combined 598 participants. Research is being sponsored by Avenzo Therapeutics, Inc., Biohaven Therapeutics Ltd., Genmab. Clinical trial participation is free and participants receive study-related medical care at no cost.

Advanced Solid Tumors Clinical Trials in Myrtle Beach — FAQ

Are there advanced solid tumors clinical trials in Myrtle Beach?

Yes, there are 3 advanced solid tumors clinical trials currently recruiting in Myrtle Beach, SC. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Myrtle Beach?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Myrtle Beach research site will contact you about next steps.

Are clinical trials in Myrtle Beach free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Myrtle Beach studies also compensate for your time and travel.

What advanced solid tumors treatments are being tested?

The 3 active trials in Myrtle Beach are testing new therapies including novel drugs, biologics, and treatment approaches for advanced solid tumors.

Data updated July 13, 2026 from ClinicalTrials.gov